The FDA should back off of 23andMe and allow the firm to continue selling its consumer genomics service because it is unlikely to lead to unnecessary diagnostic tests and medical procedures, argues Forbes writer Frida Polli.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.
By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.
SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.
A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.